Family Medicine Doctors in Bay Harbor Islands, FL Accepting Medicare

1 Family Medicine doctors found. Showing 1 - 1

Dr. Ramsey Habeeb Saffouri, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1160 Kane Concourse, Suite 400, Bay Harbor Islands, FL 33154 Phone: 305-779-0775    Fax: 305-779-1236

News Archive

NDSsi launches new DOME S10 diagnostic imaging display for mammography screening at RSNA 2010

A highly advanced 10MP diagnostic imaging display capable of showing two 5MP images for back-to-back chest wall reads has been launched by medical technology leader NDS Surgical Imaging (NDSsi). The new 30-inch widescreen Dome S10 supports 10-bit and 8-bit grayscale image data through industry standard interfaces, eliminating the need for proprietary libraries. Featuring non-reflective glass for higher-clarity viewing, and state-of-the-art 4096 x 2560 resolution, the S10 has raised the bar in optical performance in mammography screening.

New review shows how automated telephone systems could play vital role in delivery of health care

A new Cochrane Review, summarizing data from 132 trials of automated telephone systems in preventing and managing long-term health conditions, concludes that they probably have the potential to play an important role in the delivery of health care.

Prestige Care plans to join with Carson Tahoe Health to expand quality senior care services

Prestige Care, Inc., and Prestige Senior Living L.L.C., leaders in exceptional senior living and skilled nursing and rehabilitation care, today announced that they are making plans to join with Carson Tahoe Health to expand quality senior care services and offer comprehensive memory care to Carson City residents and their families. As a first step in the relationship, the organizations will develop a community with 40 units for memory care services on the Carson Tahoe Specialty Medical Center campus. Construction will begin in 2014.

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB. No financial details are disclosed.

Preclinical study results for Syk, JAK inhibitor program presented at ASH 2010

Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK inhibitors are in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Read more Medical News

› Verified 1 days ago